Exponentially increase the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence.
Scientists often spend weeks or even months sifting through research to figure out which reagents to use in specific experiments. Not only is that an inefficient process, it often doesn’t work. BenchSci’s AI-assisted platform solves this challenge by automatically ingesting and interpreting millions of historical experiments from around the world saving scientists time and money and leading to more successful experiments.
We strongly believe that opportunities within the preclinical R&D market remain largely untapped and the BenchSci team is extending the impact of its industry-leading software by driving a suite of new applications that help scientists optimize their experiment designs to maximize their chances for success.
BenchSci's Journey with Inovia
Inovia is introduced to BenchSci at Founder Fuel
Inovia leads BenchSci’s Series A
Inovia participates in the company's Series B
Dennis Kavelman joins BenchSci’s Board of Directors
Inovia co-leads Series C with TCV
More to come!